This page is part of the FHIR Specification (v0.0.82: DSTU 1). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions
FHIR Value set/code system definition for HL7 v2 table 0252 ( Causality Observations)
{ "resourceType": "ValueSet", "text": { "status": "additional", "div": "<div><p>Causality Observations</p>\r\n<table class=\"grid\">\r\n <tr><td><b>Code</b></td><td><b>Description</b></td><td><b>Version</b></td></tr>\r\n <tr><td>AW<a name=\"AW\"> </a></td><td>Abatement of event after product withdrawn</td><td>added v2.3</td></tr>\r\n <tr><td>BE<a name=\"BE\"> </a></td><td>Event recurred after product reintroduced</td><td>added v2.3</td></tr>\r\n <tr><td>DR<a name=\"DR\"> </a></td><td>Dose response observed</td><td>added v2.3</td></tr>\r\n <tr><td>EX<a name=\"EX\"> </a></td><td>Alternative explanations for the event available</td><td>added v2.3</td></tr>\r\n <tr><td>IN<a name=\"IN\"> </a></td><td>Event occurred after product introduced</td><td>added v2.3</td></tr>\r\n <tr><td>LI<a name=\"LI\"> </a></td><td>Literature reports association of product with event</td><td>added v2.3</td></tr>\r\n <tr><td>OE<a name=\"OE\"> </a></td><td>Occurrence of event was confirmed by objective evidence</td><td>added v2.3</td></tr>\r\n <tr><td>OT<a name=\"OT\"> </a></td><td>Other</td><td>added v2.3</td></tr>\r\n <tr><td>PL<a name=\"PL\"> </a></td><td>Effect observed when patient receives placebo</td><td>added v2.3</td></tr>\r\n <tr><td>SE<a name=\"SE\"> </a></td><td>Similar events in past for this patient</td><td>added v2.3</td></tr>\r\n <tr><td>TC<a name=\"TC\"> </a></td><td>Toxic levels of product documented in blood or body fluids</td><td>added v2.3</td></tr>\r\n</table>\r\n</div>" }, "identifier": "http://hl7.org/fhir/v2/vs/0252", "name": "v2 Causality Observations", "publisher": "HL7, Inc", "telecom": [ { "system": "url", "value": "http://hl7.org" } ], "description": "FHIR Value set/code system definition for HL7 v2 table 0252 ( Causality Observations)", "status": "active", "date": "2011-01-28", "define": { "system": "http://hl7.org/fhir/v2/0252", "caseSensitive": true, "concept": [ { "code": "AW", "display": "Abatement of event after product withdrawn" }, { "code": "BE", "display": "Event recurred after product reintroduced" }, { "code": "DR", "display": "Dose response observed" }, { "code": "EX", "display": "Alternative explanations for the event available" }, { "code": "IN", "display": "Event occurred after product introduced" }, { "code": "LI", "display": "Literature reports association of product with event" }, { "code": "OE", "display": "Occurrence of event was confirmed by objective evidence" }, { "code": "OT", "display": "Other" }, { "code": "PL", "display": "Effect observed when patient receives placebo" }, { "code": "SE", "display": "Similar events in past for this patient" }, { "code": "TC", "display": "Toxic levels of product documented in blood or body fluids" } ] } }